Protalix BioTherapeutics (PLX) Other Non Operating Income (2010 - 2026)

Protalix BioTherapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $188000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 55.13% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.0 million (down 15.93% YoY), while the FY2025 annual figure was $1.1 million, down 16.63% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $188000.0, down from $265000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $813000.0 in Q2 2022, with the low at -$65000.0 in Q4 2022.
• The 5-year median for Other Non Operating Income is $265000.0 (2025), against an average of $304235.3.
• Peak annual rise in Other Non Operating Income reached 535.16% in 2022, while the deepest fall reached 3150.0% in 2022.
• Protalix BioTherapeutics' Other Non Operating Income stood at -$65000.0 in 2022, then surged by 43.08% to -$37000.0 in 2023, then jumped by 405.41% to $113000.0 in 2024, then jumped by 134.51% to $265000.0 in 2025, then slipped by 29.06% to $188000.0 in 2026.
• Business Quant data shows PLX's Other Non Operating Income at $188000.0 in Q1 2026, $265000.0 in Q4 2025, and $288000.0 in Q3 2025.